Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-17-045921

Director sold 9,000 shares at an average $56.36 ($507,260)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Cantley Lewis Clayton Jr. Director 2017-07-19 Sale −3,000 $56.15 $168,450 86,697 D
Cantley Lewis Clayton Jr. Director 2017-07-19 Sale −3,000 $56.15 $168,450 86,737 I
Cantley Lewis Clayton Jr. Director 2017-07-19 Sale −500 $56.11 $28,055 86,197 D
Cantley Lewis Clayton Jr. Director 2017-07-19 Sale −500 $56.11 $28,055 86,237 I
Cantley Lewis Clayton Jr. Director 2017-07-20 Sale −500 $57.12 $28,560 85,697 D
Cantley Lewis Clayton Jr. Director 2017-07-20 Sale −500 $57.12 $28,560 85,737 I
Cantley Lewis Clayton Jr. Director 2017-07-20 Sale −500 $57.13 $28,565 85,197 D
Cantley Lewis Clayton Jr. Director 2017-07-20 Sale −500 $57.13 $28,565 85,237 I
Open-market sales · 9,000 sh · avg $56.36 · $507,260
Loading xslF345X03/doc4.xml…